In vivo studies have shown that periodontitis patients treated with anti-tumor necrosis factor-α significantly reduced IL-1β and IL-8 levels in gingival sulcus fluid and IL-8 levels in saliva (Kabwe et al., 2025). This evidence concerns the gene IL1B and periodontitis.